Mount Carmel Health System
Open enrollment with a later-stage pipeline tilt
According to ClinicalTrials.gov-derived indexes, Mount Carmel Health System sits in the upper quartile of US sponsors by registered trial count (#1,604 of 15,742 sponsors by registered trial count).
Mount Carmel Health System: 8 sponsored US clinical trials, 1 recruiting.
Mount Carmel Health System sponsors 8 registered US clinical trials on ClinicalTrials.gov, 1 of them currently recruiting, and 4 completed. 1 of these trials are in Phase 3-4 (later-stage) and 0 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Second Stage Labor, with 1 trials.
Upper-quartile sponsor footprint
Mount Carmel Health System sits in the upper quartile of the sponsor corpus (#1,604 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Open and recent trials
8 total, page 1 of 1
IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry
NCT03536897
CONNEQT Pulse Validation Study
NCT06002971
Nurse Perspectives Regarding Use of the Labor Mirror
NCT04900883
Postpartum Urinary Retention With Essential Oils (PURE)
NCT03319498
Cystogram Before Removal of Foley Catheter After Repair of Colovesical Fistula
NCT03525756
The Effect of Coffee After Resection of Small Bowel
NCT03143621
Determining Risk Factors for Successful PPI Weaning
NCT03226054
Patient Satisfaction With Propofol for Out Patient Colonoscopy
NCT02937506
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 4 | 1 |
Therapeutic Areas
Where Mount Carmel Health System enrollment is open (later-stage tilt)
1 recruiting of 8 indexed (13% open); 4 completed (50%).
Phase mix: 1 late (III/IV) vs 0 early (I/II) (later-stage heavy).
Top condition: Second Stage Labor (1 trial), 1 other listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Mount Carmel Health System: open-pipeline peers nationwide
Peers matched on 8 registered trials and 13% open enrollment, not the therapeutic-area sidebar.
Mount Carmel Health System sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 8 trials (± recruiting share)
- AB Science · 8 trials · 25% recruiting
- Abbott Point of Care · 8 trials · 25% recruiting
- Abeona Therapeutics · 8 trials · 0% recruiting
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · 8 trials · 38% recruiting
Sponsors near 13% open enrollment (± trial volume)
- Addario Lung Cancer Medical Institute · 13% recruiting · 8 trials
- American University · 13% recruiting · 16 trials
- Annexon · 13% recruiting · 8 trials
- Ansun Biopharma · 13% recruiting · 8 trials
Related
What to do with this Mount Carmel Health System page
8 registered trials is a research-attention snapshot, not an endorsement of Mount Carmel Health System or any single study.
- 1 of Mount Carmel Health System's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Second Stage Labor is the condition Mount Carmel Health System studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Second Stage Labor trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Mount Carmel Health System pipeline card: 8 registered trials from official public datasets.Report a data error.